Overview

A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma

Status:
Recruiting
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
A study of the efficacy and safety of probiotics in immunotherapy of urothelial carcinoma.
Phase:
Phase 4
Details
Lead Sponsor:
Tianjin Medical University Second Hospital